Vaccinating respiratory patients: a new landscape

Professor Francesco Blasi explains his thoughts on vaccinating respiratory patients at the 13th International Workshop On Lung Health.

New Trajectories in Lung Cancer

Professor Andrea Bianco discusses the novelties in treatement of lung cancer at the 13th International Workshop On Lung Health.

Treatment response trajectories to biologics for severe eosinophilic asthma and achievement of clinical remission - report from IWLH 2026

Professor Johann Christian Virchow discusses the treatment response trajectories to biologics for severe eosinophilic asthma and achievement of clinical remission at the 13th International Workshop On Lung Health.

Clinical remission of asthma: from biologics to inhaled drugs

Professor Giorgio Walter Canonica explains his thoughts on the clinical remission of asthma at the 13th International Workshop On Lung Health.

Adult Cystic Fibrosis

Professor Francesco Blasi explains his thoughts on the treatment of adult cystic fibrosis at the 13th International Workshop On Lung Health.

How to improve the management of newly diagnosed asthma?

Professor Guy Brusselle discusses how to improve the management of newly diagnosed asthma at the 13th International Workshop On Lung Health.

How should COPD disease characteristics guide therapeutic decisions?

Professor Dejan Radovanovic discusses how should COPD disease characteristics guide therapeutic decisions at the 13th International Workshop On Lung Health - report from IWLH 2026

Redefining epithelial driven airway inflammation: insights from clinical experience with Tezepelumab

Professor Corrado Pelaia explains his insights from clinical experience with Tezepelumab at the 13th International Workshop On Lung Health.

Increasing role of triple therapy in COPD

Professor Fabiano Di Marco ediscusses the increasing role of triple therapy in COPD at the 13th International Workshop On Lung Health.

Prevention in action: prevention in the joint action on respiratory diseaseers

Prof. Ildiko Horvath share her thoughts on prevention in the joint action on respiratory disease at ERS Congress 2025.

Current controversies in interstitial lung diseases

Prof. Catharina Moor co-chaired a very interesting session at this year's ERS congress on the current controversies in interstitial lung diseases.

The emerging therapeutic interventions for the management of interstitial lung diseases

Prof. Michael Kreuter co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic interventions for the management of interstitial lung diseases.

Addressing the generational challenge in lung health amidst the growing number of novel tobacco products

Prof. Andrew Bush share his thoughts on the generational challenge in lung health amidst the growing number of novel tobacco products at ERS Congress 2025.

Horizon scanning in the treatment of interstitial lung diseases

Dr. Nazia Chaudhuri co-chaired a very interesting session at this year's ERS congress on horizon scanning in the treatment of interstitial lung diseases.

Advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines

Prof. Job F.M. van Boven co-chaired a very interesting session at this year's ERS congress on advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines.

Thoracic oncology - Lung cancer screening updates: switch gears to move forward

Prof. Andriani Charpidou co-chaired a very interesting session at this year's ERS congress on lung cancer screening updates.

Role of immunoncology in lung cancer treatment

Immunotherapy in lung cancer

Important recent developments in oncology

EGFR and ALK mutations in NSCLC

Sequencing the mesothelioma genom

The proper treatment algorithm for non-oncogene driven NSCLC

Phase 2 trial of nivolumab in NSCLC

Multidisciplinary approach in lung cancer treatment

Immunotherapy as first-line treatment for NSCLC

LBA2_PR - EGFR mutation testing and oncologist treatment choice in advanced NSCLC

Role of checkpoint inhibitors in lung cancer treatment

Targeted therapy in lung cancer

The Lung Cancer Master Protocol

Surgical perspective of lung cancer treatment

Fight on tuberculosis

Launch of one of the world's largest ever lung health campaigns